Literature DB >> 19151691

Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage.

Gian P Bezante1, Francesca Viazzi, Giovanna Leoncini, Elena Ratto, Novella Conti, Manrico Balbi, Sergio Agosti, Luca Deferrari, Giacomo Deferrari, Roberto Pontremoli.   

Abstract

BACKGROUND: Renal dysfunction is relatively common in patients with primary hypertension (PH). A reduction in coronary vasodilator capacity has recently been reported in patients with renal damage undergoing coronary angiography. We investigated the relationship between coronary flow reserve (CFR) and early renal abnormalities in patients with PH and normal serum creatinine.
METHODS: Seventy-six untreated patients were studied. Albuminuria was measured as the albumin-to-creatinine ratio and glomerular filtration rate (eGFR) was estimated by the Cockroft-Gault formula. Chronic kidney disease (CKD) was defined as an eGFR <60 ml/min/1.73 m(2) and/or in the presence of microalbuminuria. Coronary blood flow velocities (cm/s) were measured by Doppler ultrasound at rest and after adenosine administration. CFR was defined as the ratio of hyperemic-to-resting diastolic peak velocities.
RESULTS: Prevalence of reduced eGFR, microalbuminuria, CKD, and left ventricular (LV) hypertrophy was 8, 10, 16, and 31%, respectively. Overall, 10% of patients showed impaired CFR (i.e., <2.0). Patients with CKD were more likely to be older (P < 0.05) and of female gender (P < 0.01) and showed higher LV mass index (LVMI) (P < 0.05), lower CFR (P < 0.05; analysis of covariance, P < 0.05), and CFR/LVMI (P < 0.05) than patients with normal renal function. Conversely, patients with impaired CFR showed a significantly higher prevalence of reduced eGFR (chi(2) 5.2, P < 0.05), microalbuminuria (chi(2) 10.2, P < 0.01), and CKD (chi(2) 9.2.1, P < 0.01). Even after adjustment for gender, the presence of CKD entailed a sevenfold higher risk of having impaired CFR (confidence interval 1.17-40.9, P < 0.05).
CONCLUSION: Early renal abnormalities are associated with reduced CFR in PH.

Entities:  

Mesh:

Year:  2008        PMID: 19151691     DOI: 10.1038/ajh.2008.351

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

1.  Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.

Authors:  Navkaranbir S Bajaj; Amitoj Singh; Wunan Zhou; Ankur Gupta; Kana Fujikura; Christina Byrne; Hendrik J Harms; Michael T Osborne; Paco Bravo; Efstathia Andrikopolou; Sanjay Divakaran; Courtney F Bibbo; Jon Hainer; Hicham Skali; Viviany Taqueti; Michael Steigner; Sharmila Dorbala; David M Charytan; Sumanth D Prabhu; Ron Blankstein; Rahul C Deo; Scott D Solomon; Marcelo F Di Carli
Journal:  Circulation       Date:  2019-11-29       Impact factor: 29.690

2.  Does albuminuria correlate with silent myocardial ischemia and delayed heart rate recovery in hypertensive men without diabetes mellitus.

Authors:  Johan Winata; Agnes L Panda; R Abdul Azis
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-08

Review 3.  Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence.

Authors:  Daniel S Feuer; Eileen M Handberg; Borna Mehrad; Janet Wei; C Noel Bairey Merz; Carl J Pepine; Ellen C Keeley
Journal:  Am J Med       Date:  2022-04-23       Impact factor: 5.928

4.  Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes.

Authors:  Cecilia Marini; GianPaolo Bezante; Patrizia Gandolfo; Elisa Modonesi; Silvia D Morbelli; Angelo Depascale; Daniela Rollando; Davide Maggi; Manuela Albertelli; Riccardo Armonino; Manrico Balbi; Claudio Brunelli; Renzo Cordera; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-03       Impact factor: 9.236

5.  Preclinical cardiorenal interrelationships in essential hypertension.

Authors:  Costas Tsioufis; Dimitrios Tsiachris; Alexandros Kasiakogias; Kyriakos Dimitriadis; Dimitris Petras; Dimitris Goumenos; Konstantinos Siamopoulos; Christodoulos Stefanadis
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

6.  One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.

Authors:  Mara Boschetti; Sergio Agosti; Valeria Albanese; Laura Casalino; Claudia Teti; Gian Paolo Bezante; Claudio Brunelli; Manuela Albertelli; Diego Ferone
Journal:  Endocrine       Date:  2016-04-13       Impact factor: 3.633

7.  Simultaneous cardiac and renal damage in a hypertensive population.

Authors:  Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-06       Impact factor: 3.738

8.  Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.

Authors:  Rajesh Mohandas; Mark S Segal; Tianyao Huo; Eileen M Handberg; John W Petersen; B Delia Johnson; George Sopko; C Noel Bairey Merz; Carl J Pepine
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

Review 9.  Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy?

Authors:  Ashwin Radhakrishnan; Luke C Pickup; Anna M Price; Jonathan P Law; Nicola C Edwards; Richard P Steeds; Charles J Ferro; Jonathan N Townend
Journal:  Heart       Date:  2019-06-25       Impact factor: 5.994

10.  Coronary microvascular dysfunction is associated with degree of anaemia in end-stage renal disease.

Authors:  Ashwin Radhakrishnan; Luke C Pickup; Anna M Price; Jonathan P Law; Kirsty C McGee; Larissa Fabritz; Roxy Senior; Richard P Steeds; Charles J Ferro; Jonathan N Townend
Journal:  BMC Cardiovasc Disord       Date:  2021-04-26       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.